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Conclusion. The podocyte cell in children with INS down-Cell-cycle regulatory proteins in podocyte cell in idiopathic
regulates expression of cyclin kinase inhibitors such as p21 andnephrotic syndrome of childhood.
p27, but not p57, but does not up-regulate cyclin D and cyclinBackground. The podocyte cell is believed to play an impor-
A that are needed to overcome the G1/S transition and movetant role in idiopathic nephrotic syndrome (INS) of childhood.
the cell forward in the cell cycle process. Thus, the podocyte cellIn adults with cellular and collapsing focal segmental glomeru-
remains trapped in the G1 arrest phase. In children with INSlosclerosis (FSGS), the expression of cell-cycle regulatory pro-
or AS, the dysregulated podocyte phenotype is different thanteins such as p27, p57, and cyclin D is decreased and expression
the one described in adults with cellular or collapsing FSGS.of cyclin A, Ki-67, and p21 is observed in podocyte cells sugges-
tive of a dysregulated podocyte phenotype. We investigated
for alterations in the expression of cyclin kinase inhibitors, p27,
p57, p21, and cyclins D and A in the podocyte cell of children Idiopathic nephrotic syndrome of childhood (INS) is
with INS.
a common renal disease in children. On biopsy, the com-Methods. Forty-two kidney biopsies were investigated; 14
mon histologies of INS include minimal-change diseasewith minimal-change disease (MCD), seven with diffuse mes-
(MCD), diffuse mesangial hypercellularity (DMH), and fo-angial hypercellularity (DMH), 12 with FSGS, four with Alport
syndrome (AS), and five normal biopsies. The sections were ex- cal segmental glomerulosclerosis (FSGS), which together
amined by immunohistochemistry using dual staining method. constitute 90% of childhood INS [1]. MCD is charac-
Podocyte cells were first identified by Wilm’s tumor-1 staining terized by minimal changes in the glomerulus, respondsafter which expressions of cell-cycle regulatory proteins were
well to steroid treatment, and rarely progresses to renalanalyzed. A quantitative analysis was performed for the pro-
failure. On the other end of the spectrum, FSGS is char-portion of podocyte cells that expressed each cell cycle regula-
tory protein. acterized by segmental glomerular hyalinosis and sclero-
Results. On light microscopy, all podocyte cells expressed sis, responds poorly to steroid treatment, and frequently
p27, while p57 and p21 expression was seen in a portion of progresses to renal failure [2]. The clinical course of
podocyte cells in normal kidney biopsies. Cyclin D was ex-
DMH lies between MCD and FSGS. The visceral glo-pressed in a small percent of podocyte cells though the expres-
merular epithelial cell or podocyte cell plays an impor-sion was more marked in mesangial and endothelial cells.
Cyclin A expression was not seen in normal biopsies. The mean tant role in glomerular ultrafiltration, glomerular base-
expression of p27 decreased significantly in order from normal ment membrane turnover, support for the glomerular
(100%), MCD (45.9%), DMH (22.4%), and FSGS (16.7%), capillary tuft, and formation of urine [3]. The podocyte
and the difference between MCD and FSGS was significant.
cell demonstrates significant alteration, such as efface-p21 was significantly and equally reduced in MCD (2.3%),
ment of foot processes, apical displacement of slit dia-DMH (0%), and FSGS (0.7%) compared to normal (66.6%).
phragms, and detachment of the podocyte from the glo-There was no significant difference in expression of p57, cyclin
D and cyclin A in the podocyte cells between normal and merular basement membrane in INS [4–6]. In experimental
children with INS. Children with AS showed a significant de- animals, Laurens et al [7, 8] have reproduced INS by
crease in p27 and p21 expression, while the expression of p57, isolated injury to the podocyte. We found synaptopodin,cyclin D and cyclin A were unchanged from normal, thus dem-
a podocyte protein, to decline with increasing severityonstrating a pattern similar to INS.
of INS, manifested by a decrease in synaptopodin expres-
sion from MCD to DMH to FSGS [9]. We also showed
other podocyte proteins, such as GLEPP-1 and nephrin,Key words: cyclin A, cyclin D, p21, p27, p57, idiopathic nephrotic syn-
drome, immunohistochemistry, children. to be decreased in INS [10]. It thus seems that in the
event of podocyte dysfunction/ injury, it clinically mani-Received August 30, 2002
fests as proteinuria, and at the molecular level podocyteand in revised form October 25, 2002
Accepted for publication November 21, 2002 proteins such as synaptopodin, GLEPP-1, and nephrin
become disorganized. 2003 by the International Society of Nephrology
1374
Srivastava et al: Cell-cycle proteins in nephrotic syndrome 1375
The cell-cycle process is a highly organized process from children who had normal renal biopsy following
that allows the cell to proliferate under both physiologic evaluation of loin pain-hematuria syndrome. A total of 42
and pathologic conditions. The process ensures that DNA kidney biopsies were investigated: 14 with MCD, seven
replication occurs only once and that the DNA replica- with DMH, 12 with FSGS, four with AS, and five whose
tion is completed before mitosis occurs in each cycle biopsies were normal. The age at the time of biopsy was
[11–15]. This highly organized cell-cycle process is regu- noted. Serial 3 m sections were obtained from the cases
lated by a number of cell-cycle regulatory proteins: (1) listed above, air-dried, and heat fixed on slides. The
positive cell-cycle regulatory proteins, such as “cyclins” sections were deparaffinized with xylene and iodine and
and “cyclin-dependent kinase (CDK),” which aid in the rehydrated in graded series of alcohol. The sections were
progression and completion of the cell cycle; and (2) treated with Target Retrieval Solution (Dako #S1700,
negative cell-cycle regulatory proteins, “cyclin kinase in- Dako Corp., Carpinteria, CA, USA) in a steamer at 90C
hibitors (CKI),” which inhibit the cell-cycle process. Cells to 95C for 20 minutes and then cooled for 15 minutes.
can also exit from the cell cycle at any phase by undergo- The endogenous avidin and biotin activity was blocked
ing apoptosis (death of cell), senescence (permanently by egg white and skimmed milk as described by Miller
growth-arrested cells), terminally committed specialized et al [26]. The sections were examined by immunohisto-
cells (cells can proliferate under appropriate stimuli), or chemistry using dual staining method. Podocyte cells were
be uncontrolled as in neoplasia [13]. Mature podocyte identified in the biopsy by Wilm’s tumor-1 (WT-1) stain-
cells in the glomerulus are regarded as growth-arrested ing as it is exclusively expressed in the podocyte cells in
cells that normally express negative cell-cycle regulatory the glomerulus [27]. Antihuman WT-1, a mouse mono-
proteins p27 and p57 and positive cell-cycle regulatory clonal antibody (Dako Corp.) was used in 1:100 dilution
proteins cyclin D, but not cyclin A, cyclin B1, or Ki-67 for WT-1 staining. The Universal Dako’s LSAB immu-
[16]. In adult subjects with cellular and collapsing variant nostaining system with streptavidin-biotin conjugated to
of FSGS and HIV-associated nephropathy (HIVAN), alkaline phosphatase was used for the immunohisto-
Shankland et al [17] found decreased p27 and p57 expres- chemical reaction. Vector red (Vector Laboratories, Inc.,
sion and de novo expression for p21 in podocyte cells. Burlingame, CA, USA) was used as the chromogen, which
Barisoni et al [18] reported a decrease in p27, p57, and stained WT-1 antigen red. The cell-cycle regulatory pro-
cyclin D1 expression with expression for cyclin A and teins used in the study were as follows: (1) p27 stain-
Ki-67 in podocyte cells in collapsing glomerulopathies. ing was performed with a mouse monoclonal antibody
On the other hand, Nagata et al [19] showed that the (sc-1641; Santa Cruz Biotechnology, Inc., Santa Cruz,
proliferating epithelial cells in FSGS are not podocyte CA, USA) at 1:50 dilution, (2) p21 staining with a mouse
cells but parietal epithelial cells. monoclonal antibody (sc-817; Santa Cruz Biotechnology
The podocyte is a unique glomerular cell because its Inc.) at 1:100 dilution, (3) p57 staining with a goat poly-
growth response to injury differs from the mesangial or clonal antibody (sc-1040G; Santa Cruz Biotechnology
endothelial cell by virtue of its apparent inability to pro- Inc.) at 1:50 dilution, (4) cyclin D1 staining with a mouse
liferate [13]. The podocyte cell plays an important role in monoclonal antibody (sc-8396; Santa Cruz Biotechnol-
progressive glomerulosclerosis and subsequent chronic ogy Inc.) at 1:50 dilution, and (5) cyclin A staining with
renal failure [20–23]. In childhood INS, the injury to the a rabbit polyclonal antibody (sc-751; Santa Cruz Biotech-
podocyte cell is an acquired immunologic injury, whereas
nology Inc.) at 1:100 dilution. The Universal Dako’s
in Alport syndrome (AS) the podocyte injury is subse-
LSAB  immunostaining system with streptavidin-bio-
quent to a genetic mutation in -5 of collagen type IV
tin conjugated to horseradish peroxidase was used in the
of the glomerular basement membrane [24]. We studied
immunohistochemical reaction for cell-cycle regulatorythe cell cycle regulatory protein such as p27, p57, p21,
proteins. Diaminobenzidine with 3% cobalt was used ascyclin D, and cyclin A expression in podocytes in both
the chromogen, which gave a brown-black color to cell-INS and AS to answer the question as to whether the al-
cycle antigen. In addition, a negative control using anterations in protein expression is a generalized response
irrelevant antibody, a positive control for single WT-1to podocyte injury or whether it is exclusive to INS.
immunohistochemical reaction, a positive control for sin-
gle cell-cycle regulatory protein immunohistochemical
METHODS reaction and a positive control for dual WT-1 and cell-
cycle regulatory protein immunohistochemical reactionKidney biopsies from children with INS were included
were also performed. For control immunohistochemicalin the study only if the histology was consistent with MCD,
reactions, a control kidney tissue was used for p27, p57,DMH, or FSGS as described by the International Study
and cyclin D, and a lymphoma tissue was used for p21of Kidney Disease in Children (ISKDC) [25] and the tis-
and cyclin A. In addition to the above controls for thesue in the archived paraffin block had at least five non-
sclerosed glomeruli. Control tissue (normal) was obtained experiment, positive expression of cell-cycle regulatory
Srivastava et al: Cell-cycle proteins in nephrotic syndrome1376
Table 1. Expression of p27, p21, p57, and cyclin D in podocyte cells of children with idiopathic nephrotic syndrome (INS).
The results are expressed as mean  SD
Percent-positive glomeruli Percent-positive podocyte
Normal MCD DMH FSGS Normal MCD DMH FSGS
(N  5) (N  14) (N  7) (N  12) (N  5) (N  14) (N  7) (N  12)
p27 100.00.0 66.939.5 45.637.4 39.735.3 100.00.0 45.931.5 22.428.0 16.718.9
Normal vs. (P value) — 0.291 0.058 0.015 — 0.001 0.001 0.001
MCD vs. (P value) — 0.565 0.224 — 0.203 0.028
p21 100.00.0 9.215.2 0.00.0 2.86.7 66.612.5 2.34.3 0.00.0 0.71.7
Normal vs. (P value) — 0.001 0.001 0.001 — 0.001 0.001 0.001
MCD vs. (P value) — 0.222 0.396 — 0.557 0.686
p57 100.00.0 99.12.0 86.324.9 96.47.1 60.67.0 44.718.7 37.021.5 45.018.2
Normal vs. (P value) — 0.999 0.243 0.945 — 0.351 0.138 0.385
MCD vs. (P value) — 0.095 0.931 — 0.795 0.999
Cyclin D 23.411.1 8.414.9 8.211.7 0.00.0 3.12.8 1.63.7 0.71.0 0.00.0
Normal vs. (P value) — 0.097 0.147 0.005 — 0.752 0.452 0.171
MCD vs. (P value) — 0.999 0.243 — 0.852 0.359
Abbreviations are: MCD, minimal change disease; DMH, diffuse mesangial hypercellularity; and FSGS, focal segmental glomerulosclerosis.
protein in tubular cells acted as controls within each nephrotic syndrome in 14 (42.4%) and for steroid-resis-
tant nephrotic syndrome in 12 (36.4%). The subjectssection.
Kidney biopsies stained for WT-1 and one of the cell- included 19 boys and 14 girls. There were 27 Caucasian,
four African-American, and two Asian children in thecycle regulatory proteins were first examined by light
study. Sixteen children went into remission with steroidmicroscopy. On light microscopy, evaluation of each glo-
therapy with/ without an 8-week course of cyclophospha-merulus was done for cells expressing WT-1 and cell-
mide, while the other 17 children were either steroid-cycle regulatory protein (i.e., podocyte cell expressing
resistant or steroid-dependent needing additional immu-the protein under study), WT-1 protein only (i.e., podo-
nosuppressive therapy. The total podocyte cell count percyte cell not expressing the protein under study), and
glomerulus for normal children (24.0  2.5) was notonly cell-cycle regulatory protein but not WT-1 (non-
different from MCD (19.6 3.2, P 0.47), DMH (23.2podocyte glomerular cell expressing the protein under
10.1, P  0.99), FSGS (17.3  3.6, P  0.13), or ASstudy). Following an initial qualitative assessment, a
(18.1  4.9, P  0.42).quantitative analysis for cell-cycle regulatory protein ex-
pression was performed. First, the percent of glomeruli
Normal and INSthat stained positive for the cell-cycle regulatory protein
On light microscopy, all podocyte cells in all glomeruliin the biopsy section was obtained. Next, in glomeruli
expressed p27 protein in normal children. The percentthat stained positive for cell-cycle regulatory protein,
of positive glomeruli and podocyte cells expressing p27the percent of podocyte cells that express the cell cycle
decreased in children with INS; the expression decreas-regulatory protein was obtained. The product of the above
ing in order from normal to MCD to DMH to FSGStwo values gave the proportion of total podocyte cells
(Table 1 and Fig. 1). The decrease in p27 expression inthat expressed the cell-cycle regulatory protein. To com-
podocyte cells reached statistical difference betweenpare cell-cycle regulatory protein expression and age
normal and MCD, DMH and FSGS (Table 1). The de-among the four groups of normal, MCD, DMH, and FSGS
crease was significantly more marked in FSGS comparedchildren, univariate analysis of variance (ANOVA) fol-
to MCD (Table 1). In normal children, podocyte cellslowed by Tukey HSD test was used. Student t test was
expressing p21 was observed in all glomeruli. In a givenused to compare normal with AS.
glomerulus not all podocyte cells expressed p21 (Table 1
and Fig. 1). The percent of positive glomeruli and posi-
RESULTS tive podocyte cells expressing p21 were markedly re-
duced in children with INS (Table 1 and Fig. 1). TheThe mean  SD for age in years for normal (9.7 
4.0) was not different from MCD (5.4  3.2, P  0.13), decrease in percent positive glomeruli and podocyte cells
for p21 expression reached statistical difference betweenDMH (5.3  3.6, P  0.18), FSGS (9.1  4.0, P  0.98),
or AS (10.4  2.2, P  0.78). The age difference among normal and MCD, DMH, and FSGS (Table 1). There
was no difference within the INS group of MCD, DMH,children with INS (MCD, DMH, and FSGS) was not
statistically different either. The biopsies were per- and FSGS (Table 1). In normal children, all glomeruli
had podocyte cells that expressed p57 protein but likeformed for associated hematuria in seven (21.2%), for
steroid sensitive frequently relapsing/ steroid dependent p21 not all podocyte cells in the glomeruli expressed p57
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Fig. 1. Photomicrograph shows the expression of p27, p21, p57, cyclin D, and cyclin A in podocyte cells of normal and children with minimal
change disease (MCD), diffuse mesangial hypercellularity (DMH), and focal segmental glomerulosclerosis (FSGS) in kidney tissue. The podocyte
cell is identified by Wilm’s tumor (WT-1) expression (stained red with Vector red) and the cell-cycle regulatory protein is stained brown-black
with diaminobenzidine with 3% cobalt. Only podocyte cells that showed homogenous and intense expression of cell cycle regulatory protein above
the background were accepted as positive expression. The expression for p27 decreased in order from normal to MCD to DMH to FSGS. p21
expression was markedly decreased in children with MCD, DMH, or FSGS compared to normal. The expression for p57 remained unchanged
between normal, MCD, DMH, and FSGS. Cyclin D expression was similar between normal, MCD, DMH, and FSGS. Cyclin A expression was
not observed in either normal, MCD, DMH, or FSGS.
(Table 1 and Fig. 1). There was no difference in percent D expression in normal and children with INS and within
the INS group of MCD, DMH, and FSGS (Table 1).of positive glomeruli or percent positive podocyte cells
expressing p57 in normal and children with INS and On light microscopy, cyclin A was not expressed in the
podocyte cells of either normal children or children withwithin the INS group of MCD, DMH, and FSGS (Ta-
ble 1). On light microscopy, cyclin D was predominantly INS (Fig. 1).
observed in endothelial and mesangial cells in the glo-
Normal and ASmeruli although a small percentage of glomeruli and
podocyte cells did express cyclin D in normal children The podocyte expression of p27 and p21 was signifi-
cantly decreased in children with AS (p27, 63.5  17.0;(Table 1 and Fig. 1). There was no difference in cyclin
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p21, 18.9  13.5) when compared with normal children ment or function, it does get up- or down-regulated in
response to an exogenous insult. In adults, p27 is reported(p27, 100  0.0, P  0.04; p21, 66.6  12.5, P  0.01).
There was no difference in podocyte expression of p57 to be decreased in cellular and collapsing variant of
FSGS and HIVAN, but unchanged in MCD [17]. In ourand cyclin D between normal children (p57, 60.6  7.0;
cyclin D, 3.1  2.8) and AS (p57, 58.4  10.4, P  0.68; study we observed a significant decrease in p27 expres-
sion in podocyte cells in children with INS, decreasingcyclin D, 6.3 1.5, P 0.14). Cyclin A was not expressed
in the podocyte cells of either normal or children with in order from normal to MCD to DMH to FSGS. The
decrease in p27 expression observed in our study is pro-AS. The pattern of changes observed in AS biopsies was
thus similar to those with INS. portional to the severity of the injury. Unlike Shankland
et al [17], we found a difference between MCD and nor-
mal, which could be attributed to a quantitative assess-
DISCUSSION
ment performed by us rather than a qualitative assessment
In recent times, cell-cycle regulatory proteins have for p27 expression.
become an area of intense research in order to under- Could the observed difference in p27 expression be-
stand the changes that occur in various renal diseases. tween INS and normal children be due to loss of podo-
The roles of these proteins in renal diseases have been cyte cells from the glomerulus or be age-related? Loss
addressed in several reviews [11–15]. Our earlier work on of podocytes from the glomerulus cannot explain the
podocyte cells in childhood INS indicated that podocyte decrease in p27 expression, as unlike children with in-
dysfunction/ injury is clinically manifested as proteinuria, flammatory glomerulonephritis, loss of podocytes in the
while at the molecular level, podocyte proteins such as urine is not observed in children with MCD [35]. The
synaptopodin, GLEPP-1, and nephrin become disorga- total podocyte count per glomerulus was not different
nized [9, 10]. Thus, we believe that understanding the among the four groups. WT-1 and p57 are expressed
podocyte’s response following injury is critical to our only in the podocyte cells of the glomerulus [27, 36]. The
understanding of the pathophysiology of INS. In adult normal expression of WT-1 as observed in our earlier
subjects with cellular and collapsing variants of FSGS study and p57 in this study, in both normal and children
and HIVAN, the podocyte cells were observed to have with INS supports the fact that the observations are not
decreased p27, p57, and cyclin D expression and positive related to loss of podocyte cells [9]. There was no signifi-
staining for p21, cyclin A, and Ki-67 suggestive of a dys- cant difference between the ages of children with MCD,
regulated podocyte phenotype [17, 18]. In contrast, Na- DMH, FSGS, and normal children. Thus, the changes
gata et al [19] has contested that the proliferating epithe- observed in p27 expression could not be attributed to
lial cells in FSGS are not podocyte cells but parietal the age of the patient.
epithelial cells. These observations led us to investigate The p21 protein is thought to play an important role
for alterations in expression of cell-cycle regulatory pro- at the G1 checkpoint [37]. In our study we observed p21
teins in podocyte cells in children with INS. To overcome expression in normal kidney unlike Shankland et al [17]
the issue of podocyte cell versus parietal epithelial cell, who had not detected p21 in normal tissue, and a sig-
we identified the podocyte cell by WT-1 expression, nificant decrease in p21 expression in podocyte cells in
based on Mundlos et al [27] observation that WT-1 pro- children with INS. The p21 CKI is rapidly induced in re-
tein is exclusively expressed in podocyte cells. In our sponse to physiologic and chemical inducers of differen-
earlier study using the same biopsy material, we had shown tiation and p21 gene is a candidate gene linking differen-
normal WT-1 expression in podocyte cells of children tiation signals to G1 arrest in multiple cell lines [38]. The
with INS [9]. This technique allows study of the cell- p21 expression is believed to be regulated by both a p53
cycle regulatory proteins expressed solely in podocytes dependent and a p53 independent pathway [38]. Englert
excluding other resident cells of the glomerulus. et al [39] have shown that WT-1 gene induces an increase
p27 is believed to play a role in differentiation of cells, expression of p21 mRNA independent of p53, and in the
maintain podocyte cells in quiescence by cell cycle arrest kidney p21 is expressed in the differentiating glomerular
in G1 phase, and modulate apoptosis and cell-cycle exit podocytes along with WT-1, which, in turn, may contrib-
response to antimitogenic cues [16, 28]. In p27 knockout ute to WT-1–dependent differentiation pathways in the
mice, the kidneys are 25% larger due to a proportionate kidney. Englert et al [39] study suggests a close functional
increase in all resident cell types, no renal histologic relationship between WT-1 and p21. WT-1 and p21 play
changes are observed by light or electron microscopy, an important role for cell differentiation and G1 cell ar-
and renal function is normal [29–32]. In animal models rest. The podocyte cell is characterized by arrest in G1
of glomerulonephritis, the changes in p27 are variable, phase and abundant expression of WT-1. Thus, our find-
it is decreased in Thy-1 model, and increased in passive ing of p21 in podocytes in normal kidney unlike Shank-
Heymann nephritis [33, 34]. Although the complete ab- land et al [17] was not an unexpected observation based
on earlier studies showing close functional relationshipsence of p27 does not have an impact on renal develop-
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between WT-1 and p21 in cell differentiation and G1 Cyclin D is required for cell proliferation and G1/S
cell arrest. We could speculate that difference in p21 transition and works through inactivation the retinoblas-
expression between Shankland study [17] and ours could toma protein [13]. In Thy-1 and passive Heymann nephri-
be related to the epitope recognition site of the antibody tis models of glomerulonephritis, cyclin D is unchanged
used in the two studies. The antibody used by us was [33, 34]. In our study, we did not observe any difference
clone 187, produced by immunization with full-length in cyclin D expression in podocyte cells in normal and
p21 of human origin. The antibody used by Shankland children with INS, which is consistent with animal data,
et al [17] was from clone SX 118, which is raised against but stands in contrast to Barisoni et al [18] who found
a purified recombinant human p21-glutathione-S-trans- cyclin D to be decreased in collapsing FSGS. We found
ferase (GST) fusion protein and only recognizes the pro- cyclin D to be predominantly expressed in the endothe-
liferating cell nuclear antigen (PCNA)–binding domain lial and mesangial cells of the glomerulus. Cyclin A in-
of p21. It is possible that our antibody recognizes an crease in late G1, and peaks in S and G2 phase, and is
epitope of p21 different from the PCNA binding site as required for onset of DNA synthesis and to overcome
we found consistent results with normal kidney tissue G1/S block [13]. In our study, we did not observe anyfrom children with Wilm’s tumor (data not shown) and expression in cyclin A in podocyte cells in normal and
abnormal tissue from children with congenital nephrotic
children with INS. The difference in our observation
syndrome of Finnish type (data not shown).
from Barisoni et al [18] is discussed above.p57 is believed to play a role in the terminal differenti-
Children with AS had similar changes in cell-cycleation of podocyte cell and overexpression of p57 arrests
regulatory proteins as those with INS, with decrease inthe cell in G1 phase [40, 41]. The p57 knockout mice
p27 and p21 expression, unchanged expression of p57develop noncystic medullary dysplasia in the kidneys
and cyclin D, and absent cyclin A. Thus, it appears thatand have many features that resemble Beckwith-Weider-
the changes observed following an acquired immuno-mann syndrome [36]. Although p57 was reported de-
logic injury to podocyte cell in children with INS arecreased in cellular and collapsing variant of FSGS, we did
similar to the changes observed in AS, which resultsnot observe any difference in p57 expression in podocyte
from a genetic mutation in 5 of collagen type IV of thecells in normal and children with INS [17, 18]. The cellu-
glomerular basement membrane. In our earlier studieslar and collapsing variant of FSGS is a small subset of
we had found the expression of synaptopodin, GLEPP-1,FSGS in adults [42]. In our own series of 34 children
and nephrin to be decreased in both children with INSwith FSGS from 1984 to 1995 seen at our institution, we
did not find a single child with cellular or collapsing (acquired immunologic injury to podocyte cell) and chil-
variant of FSGS, which is a rare entity in children [1]. In dren with Galloway-Mowat syndrome and congenital
the present study, children had classic FSGS. Currently, nephrotic syndrome of the Finnish type (podocyte dys-
there are no studies available either in adults or children function following genetic mutations) [9, 10]. Thus, the
with podocyte expression of p57 in subjects with classic changes in the cell-cycle regulatory proteins observed
FSGS to make a suitable comparison. The dysregulated by us might indicate a final common pathway to different
podocyte phenotype as described in adults for the subset injury processes to the podocyte cell.
of cellular and collapsing FSGS was not observed in There was no statistical difference between expression
children with classic FSGS. Yang, Gubler, and Beaufils of podocyte cell-cycle regulatory proteins and clinical
[43] using other proliferation and podocyte markers response to steroids, nor was there statistical difference
found an abnormal distribution of WT-1 and PAX-2, and in expression of cell-cycle regulatory proteins between
extensive loss of podocyte markers in idiopathic collaps- Caucasian and African American children (data not
ing glomerulopathy and HIVAN; this dysregulation was
shown). Only four children in our series had either ele-
associated with podocyte proliferation without detect-
vated serum creatinine or had progressed to end stageable apoptosis, while in FSGS, proliferation was not ob-
renal failure, hence we did not correlate cell-cycle regula-served, which indirectly supports our finding of absence
tory protein expression and renal outcome as the sampleof a proliferative podocyte phenotype in childhood INS.
size was too small. The study was limited, as children withIn addition, Nagata et al [19] have suggested that the
mild MCD are not routinely biopsied; thus, our MCDhyperplastic cell in FSGS is the parietal epithelial cell
group was skewed toward moderate to severe MCD. Weand not podocyte cell. Thus, the above studies, combined
can cautiously speculate that inclusion of mild MCDwith our own study would suggest that the subset of
cases would not have altered our results much, as thecollapsing and cellular FSGS and HIVAN may have a
difference between normal and MCD showed a dichoto-different pathogenic pathway from INS, where prolifera-
mous pattern in which either marked difference exists,tion is absent. The absence of proliferative dysregulated
as in the case of p21 and p27, or no difference is seenpodocyte phenotype in childhood INS is further sup-
ported by our data on cyclin D and cyclin A (vide infra). as in the case of p57, cyclin D, and cyclin A.
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